GSK2656157 manufacturer | purchase GSK2656157 | GSK-2656157 supplier | GSK2656157 distributor

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
5 mg	In-stock	$350.00	Visible after login	- +
10 mg	In-stock	$500.00	Visible after login	- +
25 mg	In-stock	$850.00	Visible after login	- +
50 mg	3-5days	$1200.00	Visible after login	- +

Size

Availability

Price(USD)

VIP Price (USD)

Quantity

5 mg

In-stock

$350.00

Visible after login

- +

10 mg

In-stock

$500.00

Visible after login

- +

25 mg

In-stock

$850.00

Visible after login

- +

50 mg

3-5days

$1200.00

Visible after login

- +

Product Overview

Product Name	GSK2656157 (Synonyms: GSK-2656157)
CAS	1337532-29-2
Formula	C23H21FN6O
MW	416.45
Appearance	Off-white to light yellow powder
Storage condition	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

Product details

GSK2656157 is an ATP-competitive and highly selective inhibitor of PERK with IC50 of 0.9 nM in a cell-free assay, 500-fold greater against a panel of 300 kinases. GSK2656157 decreases apoptosis and inhibits excessive autophagy.
Keywords: buy GSK2656157 | GSK2656157 supplier | purchase GSK2656157 | GSK2656157 cost | GSK2656157 manufacturer | order GSK2656157 | GSK2656157 distributor

Related literature

Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity.

PMID: 23333938 DOI: 10.1158/0008-5472.CAN-12-3109

GSK2656157, a PERK inhibitor, reduced LPS-induced IL-1β production through inhibiting Caspase 1 activation in macrophage-like J774.1 cells.

PMID: 27251848 DOI: 10.1080/08923973.2016.1192191

Evidence for eIF2α phosphorylation-independent effects of GSK2656157, a novel catalytic inhibitor of PERK with clinical implications.

PMID: 24401334 PMCID: PMC3979916 DOI: 10.4161/cc.27726

Sorry, no related items

History

CL1099

GSK2656157 (Synonyms: GSK-2656157)

1337532-29-2 98+%